EP
Eupraxia Pharmaceuticals Inc. (EPRX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$7.20
+3.19%
Mkt Cap $451.28M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | — | — | — | -$0.16 | -$0.37 | -131.25% |
| Q4 2025 Nov 4, 2025 | — | — | — | -$0.23 | -$0.19 | +17.39% |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.21 | -$0.26 | -23.81% |
| Q2 2025 May 6, 2025 | — | — | — | -$0.19 | -$0.21 | -10.53% |
| Q1 2025 Mar 20, 2025 | — | — | — | -$0.18 | -$0.21 | -16.67% |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.13 | -$0.17 | -30.05% |
| Q3 2024 Aug 7, 2024 | — | — | — | -$0.17 | -$0.17 | -0.37% |
| Q2 2024 May 8, 2024 | — | — | — | -$0.17 | -$0.21 | -23.25% |
| Q1 2024 Mar 21, 2024 | — | $2.98M | — | — | -$0.15 | — |
| Q3 2023 Sep 30, 2023 | — | — | — | -$0.11 | -$0.25 | -124.05% |
| Q2 2023 Jun 30, 2023 | — | — | — | -$0.27 | -$0.36 | -30.95% |
| Q1 2023 Mar 31, 2023 | — | — | — | -$0.17 | -$0.23 | -34.38% |
| Q4 2022 Dec 31, 2022 | $8.48M | — | — | -$0.13 | -$0.41 | -225.81% |
| Q3 2022 Sep 30, 2022 | — | — | — | -$0.31 | -$0.22 | +29.96% |
| Q2 2022 Jun 30, 2022 | — | — | — | -$0.30 | -$0.31 | -3.72% |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.26 | — |
| Q4 2021 Dec 31, 2021 | — | — | — | -$0.27 | -$0.30 | -10.30% |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.35 | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.41 | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$1.13 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.01 | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$0.08 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.08 | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.17 | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$0.14 | — |
| Q3 2019 Sep 30, 2019 | — | — | — | — | -$0.14 | — |